Latest News and Press Releases

Villers-lès-Nancy, le 30 avril 2025 - 08h00 (CET) COMMUNIQUE DE PRESSE ENTREE EN NEGOCIATION EXCLUSIVE AVEC UN EDITEUR DE SOLUTIONS LOGICIELLES FRANÇAIS POUR L'ACQUISITION DE DEUX ACTIVITES...

Villers-lès-Nancy, 30 April 2025 - 8:00 AM (CET) PRESS RELEASE EXCLUSIVE NEGOTIATIONS INITIATED WITH A FRENCH SOFTWARE EDITOR TO ACQUIRE TWO SOFTWARE PUBLISHING BUSINESSES OPERATING IN THE PUBLIC...

Robbins LLP is Investigating Allegations that Geron Corporation (GERN) Misled Investors Regarding the Launch and Potential Growth of Rytelo

Robbins LLP is Investigating Allegations that Treace Medical Concepts, Inc. (TMCI) Misled Investors Regarding Demand for its Primary Product

PHILADELPHIA, March 31, 2025 (GLOBE NEWSWIRE) -- Rachel Yudkowsky, MD, MHPE, was selected as the recipient of NBME’s 2025 John P. Hubbard Award. For more than 40 years, this annual award has...

Robbins LLP is Investigating Allegations that Pacira BioSciences, Inc. (PCRX) Failed to Disclose its Lack of Patent Protection for Exparel

Robbins LLP is Investigating Allegations that TransMedics Group, Inc. (TMDX) Misled Investors Regarding its Coercive and Unsafe Business Practices

Robbins LLP is Investigating Allegations that Intellia Therapeutics, Inc. (NTLA) Misled Investors Regarding the Viability of its Drug Candidate

Robbins LLP is Investigating Allegations that ICON PLC (ICLR) Misled Investors Regarding Demand

Robbins LLP is Investigating Allegations that BioAge Labs, Inc. (BIOA) Misled Investors Regarding its Lead Drug Candidate in Connection with its IPO